Request for Public Comment: 60-Day Proposed Information Collection: Behavioral Health Preventive Care Assessment Focus Group Guide; Correction, 32032 [E8-12509]
Download as PDF
<![CDATA[
yshivers on PROD1PC62 with NOTICES
32032
Federal Register / Vol. 73, No. 109 / Thursday, June 5, 2008 / Notices
Hoffman-La Roche, Inc., for the
proposed treatment of adult patients
with moderately to severely active
rheumatoid arthritis.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/ohrms/
dockets/ac/acmenu.htm, click on the
year 2008 and scroll down to the
appropriate advisory committee link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before July 15, 2008. Oral
presentations from the public will be
scheduled between approximately 12:45
p.m. and 1:45 p.m. Those desiring to
make formal oral presentations should
notify the contact person and submit a
brief statement of the general nature of
the evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before July 7, 2008. Time allotted for
each presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by July 8, 2008.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Nicole
Vesely at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/oc/advisory/
default.htm for procedures on public
conduct during advisory committee
meetings.
VerDate Aug<31>2005
14:51 Jun 04, 2008
Jkt 214001
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: May 27, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E8–12646 Filed 6–4–08; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Request for Public Comment: 60-Day
Proposed Information Collection:
Behavioral Health Preventive Care
Assessment Focus Group Guide;
Correction
ACTION:
Notice; correction.
SUMMARY: The Indian Health Service
published a document in the Federal
Register (FR) on April 29, 2008. The
document contained one error.
FOR FURTHER INFORMATION CONTACT:
Christina Rouleau, Office of
Management Services, Indian Health
Service, 801 Thompson Avenue, Suite
450, Rockville, MD 20852, Telephone
(301) 443–5938. (This is not a toll-free
number.)
Correction
In the Federal Register of April 29,
2008, in FR Doc. E8–9258, on page
23254, in the second column, second
paragraph, under SUMMARY, correct
Domestic/Intimate Partner Violence
screening in women ages 14–15 to read:
Domestic/Intimate Partner Violence
screening in women ages 15–40.
Dated: May 29, 2008.
Robert G. McSwain,
Director, Indian Health Service.
[FR Doc. E8–12509 Filed 6–4–08; 8:45 am]
BILLING CODE 4165–16–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Allergy, Immunology,
and Transplantation Research Committee;
Allergy, Immunology and Transportation
Research Committee (AITRC).
Date: June 24, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: DoubleTree Hotel, 1515 Rhode
Island Ave., NW., Director’s Room 2nd Floor,
Washington, DC 20005.
Contact Person: Katrin Eichelberg, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda MD 20892, (301) 496–
0818, keichelberg@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: May 27, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–12282 Filed 6–4–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, June
30, 2008, 8 a.m. to July 1, 2008, 5 p.m.,
Doubletree Hotel, 1515 Rhode Island
Avenue, NW., Washington, DC 20005,
which was published in the Federal
Register on May 15, 2008, 73 FR 28122–
28123.
The meeting will be held one day
only, June 30, 2008. The meeting time
and location remain the same. The
meeting is closed to the public.
Dated: May 27, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–12275 Filed 6–4–08; 8:45 am]
BILLING CODE 4140–01–M
E:\FR\FM\05JNN1.SGM
05JNN1
]]>Agencies
[Federal Register Volume 73, Number 109 (Thursday, June 5, 2008)]
[Notices]
[Page 32032]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-12509]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Indian Health Service
Request for Public Comment: 60-Day Proposed Information
Collection: Behavioral Health Preventive Care Assessment Focus Group
Guide; Correction
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Indian Health Service published a document in the Federal
Register (FR) on April 29, 2008. The document contained one error.
FOR FURTHER INFORMATION CONTACT: Christina Rouleau, Office of
Management Services, Indian Health Service, 801 Thompson Avenue, Suite
450, Rockville, MD 20852, Telephone (301) 443-5938. (This is not a
toll-free number.)
Correction
In the Federal Register of April 29, 2008, in FR Doc. E8-9258, on
page 23254, in the second column, second paragraph, under SUMMARY,
correct Domestic/Intimate Partner Violence screening in women ages 14-
15 to read: Domestic/Intimate Partner Violence screening in women ages
15-40.
Dated: May 29, 2008.
Robert G. McSwain,
Director, Indian Health Service.
[FR Doc. E8-12509 Filed 6-4-08; 8:45 am]
BILLING CODE 4165-16-M
